Browse studies

Find your next paid study

4,619 recruiting studies matching your filters

A Phase 3b, Multicenter, Open-label, Single-arm Trial to Evaluate the Efficacy and Safety of Orally Administered Centanafadine QD XR Capsules in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/…

Attention-deficit/Hyperactivity DisorderEmotional Dysregulation

Estimated

~$10 – $8,750

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07759154

Observational

Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System Model 5101 (R20) for the Indication of Overactive Bladder (OAB)

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.

Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Overactive Bladder (OAB)

Estimated

~$10 – $8,750

Axonics, Inc.NCT06789406

Acquisition of Data, Blood, and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating ho…

Non-GI CancersCancer of Gastrointestinal TractGastrointestinal Cancer

Estimated

~$10 – $675

National Cancer Institute (NCI)NCT01313442

Observational

A Randomized, Controlled, Blinded, Prospective, Multi-center Study Evaluating Tensi+ With Transcutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder Syndrome

The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for t…

Overactive Bladder (OAB)

Estimated

~$10 – $7,500

Stimuli TechnologyNCT07300904

Phase 1

A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell Malignancies

The purpose of this study is to measure the safety, preliminary antitumor activity, pharmacokinetics, and pharmacodynamics with tacabrutideg in combination wit…

B-cell MalignancyRelapsed CancerRefractory Cancer+1 more

Estimated

~$10 – $7,500

BeOne MedicinesNCT06634589

Phase 1

Phase 1 Randomized Double-Blind Placebo-Controlled Safety Study of MucoCept-CVN (Lactobacillus Jensenii 1153-1666) Administered Vaginally to Healthy Women

MucoCept-CVN uses a Lactobacillus strain native to the human vagina that is modified into a live biotherapeutic product (LBP) that continuously expresses a pot…

HIV -1 Infection

Estimated

~$10 – $7,500

Craig Cohen, MD, MPHNCT07181486

Phase 3

A Phase III, Randomized, Double-Blind, Placebo Controlled Clinical Trial Evaluating the Benefits and Mechanism Of Action Of Angiotensin-II Receptor Blocker On Cardiovascular Remodeling In Patients With Repaired Coarctation Of Aorta

The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.

Coarctation of AortaHigh Blood Pressure

Estimated

~$10 – $6,250

Mayo ClinicNCT06150560

Phase 3

A Randomized, Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan Versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First Line Treatment of HER2-positive Gastric Cancer (ARTEMIDE-Gastric01)

This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and safety of rilvegostomig in combination …

HER2-positive Gastric CancerGastroesophageal Junction Adenocarcinoma

Estimated

~$10 – $7,500

AstraZenecaNCT06764875

Phase 4

Comparative Effectiveness of Positive Airway Pressure Therapy, Dental Device, and Atomoxetine-Oxybutynin for Sleep Apnea: the ADAPT-OSA Study

Researchers want to identify which treatments for obstructive sleep apnea (OSA) work best and are easiest for patients to use consistently. Eligible participan…

Obstructive Sleep Apnea (OSA)

Estimated

~$10 – $7,500

Sairam ParthasarathyNCT07679282

Phase 2

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (With 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety

This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasib…

Refractory AnginaCoronary Artery Disease

Estimated

~$10 – $8,750

XyloCor Therapeutics, Inc.NCT07048808

Observational

Urine Resazurin Reduction Ratio and Phenotypic Antibiotic Susceptibility Testing: A Rapid Diagnostic Tool for Urinary Tract Infection and Lower Urinary Tract Dysfunction Using a Catheter

Patients who seek care through MedStar National Rehab Hospital's clinic believing they have a UTI will be enrolled in this trial. They will be pre-screened aft…

Neurogenic Bladder DisorderLower Urinary Tract DisorderUrinary Tract Infection (Diagnosis)

Estimated

~$10 – $7,500

Medstar Health Research InstituteNCT07784829

Single Dose Amikacin for Uncomplicated Cystitis in the Emergency Department (ED): A Feasibility Study

The purpose of this study is to determine if a single dose of amikacin (a type of antibiotic) can be used to effectively treat emergency department patients wi…

Urinary Tract Infections

Estimated

~$10 – $1,125

Antonios LikourezosNCT05227937